1224209

Novo Nordisk A/S — FEI 3009341839

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 17, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Soborg (Denmark)

Additional Details

Sponsor, Contract Research Organization